Cocaine cardiotoxicity: A review of the pathophysiology, pathology, and treatment options

American Journal of Cardiovascular Drugs

Volumn 9, Issue 3, 2009, Pages 177-196

  Phillips, Katharine ^a   Luk, Adriana ^a   Soor, Gursharan S ^a   Abraham, Jonathan R ^a   Leong, Shaun ^a   Butany, Jagdish ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; COCAINE; NITROPRUSSIDE SODIUM; SODIUM CHANNEL;

ALERTNESS; ASYSTOLE; ATHEROSCLEROSIS; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; CAUSE OF DEATH; COCAINE DEPENDENCE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY CONSTRICTION; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; DRUG INTOXICATION; ELECTROCARDIOGRAM; EUPHORIA; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MYOCARDITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SODIUM TRANSPORT; SUDDEN DEATH; THORAX PAIN; THROMBOGENESIS; UNITED STATES;

ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; COCAINE; DEATH, SUDDEN, CARDIAC; HEART; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; PRACTICE GUIDELINES AS TOPIC;

EID: 66849122071     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200909030-00005     Document Type: Review

References (189)

1. Grinspoon L, Bakalar JB. Coca and cocaine as medicines: an historical review. J Ethnopharmacol 1981 Mar-May; 3 (2-3): 149-59
2. National Institute on Drug Abuse. Cocaine abuse and addiction. Bethesda (MD): National Institute of Health, 2004 Nov. Report no.: NIH-99-4342
3. Jeri FR. Coca-paste smoking in some Latin American countries: a severe and unabated form of addiction. Bull Narc 1984 Apr-Jun; 36 (2): 15-31
4. Cornish JW, O'Brien CP. Crack cocaine abuse: an epidemic with many public health consequences. Annu Rev Public Health 1996; 17: 259-73
5. Billman GE. Mechanisms responsible for the cardiotoxic effects of cocaine. Faseb J 1990 May; 4 (8): 2469-75
6. Farrar HC, Kearns GL. Cocaine: clinical pharmacology and toxicology. J Pediatr 1989 Nov; 115 (5 Pt 1): 665-75
7. Jones RT. The pharmacology of cocaine smoking in humans. In: Chiang CN, Hawks RL, editors. NIDA Research Monograph 99: research findings of smoking of abused substances. Washington, DC: United States Government Printing Office, 1990: 30-41
8. Ellenhorn MJ, Barceloux DG, editors. Medical toxicology: diagnosis and treatment of human poisoning. New York: Elsevier, 1988
9. Chow MJ, Ambre JJ, Ruo TI, et al. Kinetics of cocaine distribution, elimination, and chronotropic effects. Clin Pharmacol Ther 1985 Sep; 38 (3): 318-24
10. Hollander JE, Henry TD. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin 2006 Feb; 24 (1): 103-14
11. Cone EJ, Tsadik A, Oyler J, et al. Cocaine metabolism and urinary excretion after different routes of administration. Ther Drug Monit 1998 Oct; 20 (5): 556-60
12. Vitti T, Boni R. Metabolism of cocaine. In: Barnett G, Chiang CN, editors. Pharmacokinetics and pharmacodynamics of psychoactive drugs: a research monograph. Foster City (CA): Biomedical Publications, 1985: 427-40
13. Javaid JI, Musa MN, Fischman M, et al. Kinetics of cocaine in humans after intravenous and intranasal administration. Biopharm Drug Dispos 1983 Jan-Mar; 4 (1): 9-18
14. Barnett G, Hawks R, Resnick R. Cocaine pharmacokinetics in humans. J Ethnopharmacol 1981 Mar-May; 3 (2-3): 353-66
15. Ambre JJ, Belknap SM, Nelson J, et al. Acute tolerance to cocaine in humans. Clin Pharmacol Ther 1988 Jul; 44 (1): 1-8
16. Fendrich M, Johnson TP, Sudman S, et al. Validity of drug use reporting in a high-risk community sample: a comparison of cocaine and heroin survey reports with hair tests. Am J Epidemiol 1999 May 15; 149 (10): 955-62
17. Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc 2008 Jan; 83 (1): 66-76
18. Baker JE, Jenkins AJ. Screening for cocaine metabolite fails to detect an intoxication. Am J Forensic Med Pathol 2008 Jun; 29 (2): 141-4
19. Bush DM. The U.S. mandatory guidelines for federal workplace drug testing programs: current status and future considerations. Forensic Sci Int 2008 Jan 30; 174 (2-3): 111-9
20. United Nations Office on Drugs and Crime. World Drug Report. Vienna: United Nations, 2008
21. McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008 Apr 8; 117 (14): 1897-907
22. Mittleman MA, Mintzer D, Maclure M, et al. Triggering of myocardial infarction by cocaine. Circulation 1999 Jun 1; 99 (21): 2737-41
23. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Emergency department trends from the drug abuse warning network, final estimates, 1995-2002. Rockville (MD): United States Department of Health and Human Services, 2003. Report no.: DAWN Series: D-24, DHHS Publication No. (SMA) 03-3780
24. White SM, Lambe CJ. The pathophysiology of cocaine abuse. J Clin Forensic Med 2003 Mar; 10 (1): 27-39
25. Weber JE, Chudnofsky CR, Boczar M, et al. Cocaine-associated chest pain: how common is myocardial infarction? Acad Emerg Med 2000 Aug; 7 (8): 873-7
26. Drug Abuse Warning Network, 2005. National estimates of drug-related emergency department visits. Rockville (MD): United States Department of Health and Human Services, 2007. DAWN Series D-29, DHHS Publication No. (SMA) 07-4256
27. Darke S, Kaye S, Duflou J. Cocaine-related fatalities in New South Wales, Australia 1993-2002. Drug Alcohol Depend 2005 Feb 14; 77 (2): 107-14
28. Reynolds M, Pinto D, Josephson M. Sudden cardiac death. In: Fuster V, O'Rourke R, Walsh R, et al., editors. Hurst's the heart. 12th ed. New York (NY): McGraw-Hill Medical, 2008: 1161-86
29. Karch SB. Cocaine cardiovascular toxicity. South Med J 2005 Aug; 98 (8): 794-9
30. Blaho K, Logan B, Winbery S, et al. Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED. Am J Emerg Med 2000 Sep; 18 (5): 593-8
31. Frishman WH, Del Vecchio A, Sanal S, et al. Cardiovascular manifestations of substance abuse part 1: cocaine. Heart Dis 2003 May-Jun; 5 (3): 187-201
32. Feldman JA, Fish SS, Beshansky JR, et al. Acute cardiac ischemia in patients with cocaine-associated complaints: resultsofamulticenter trial. Ann Emerg Med 2000 Nov; 36 (5): 469-76
33. Tokarski GF, Paganussi P, Urbanski R, et al. An evaluation of cocaine-induced chest pain. Ann Emerg Med 1990 Oct; 19 (10): 1088-92
34. American Heart Association. Heart disease and stroke statistics: 2008 update. Dallas (TX): American Heart Association, 2008
35. Benzaquen BS, Cohen V, Eisenberg MJ. Effects of cocaine on the coronary arteries. Am Heart J 2001 Sep; 142 (3): 402-10
36. Lange RA, Cigarroa JE, Hillis LD. Theodore E. Woodward award: cardiovascular complications of cocaine abuse. Trans Am Clin Climatol Assoc 2004; 115: 99-114
37. Lange RA, Cigarroa RG, Yancy Jr CW, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989 Dec 7; 321 (23): 1557-62
38. Moliterno DJ, Willard JE, Lange RA, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994 Feb 17; 330 (7): 454-9
39. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 2001 Jun; 14 (6 Suppl.): 83S-9S
40. Masson S, Latini R, Anand IS, et al. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT). J Card Fail 2006 Jun; 12 (5): 375-80
41. Fandino J, Sherman JD, Zuccarello M, et al. Cocaine-induced endothelin-1-dependent spasm in rabbit basilar artery in vivo. J Cardiovasc Pharmacol 2003 Feb; 41 (2): 158-61
42. Wilbert-Lampen U, Seliger C, Zilker T, et al. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubation with sigma-receptor antagonists. Circulation 1998 Aug 4; 98 (5): 385-90
43. Dhawan SS, Wang BW. Four-extremity gangrene associated with crack cocaine abuse. Ann Emerg Med 2007 Feb; 49 (2): 186-9
44. Pradhan L, Dabisch PA, Liles JT, et al. Effect of acute intravenous cocaine administration on endothelium-dependent vasodepressor responses to acetylcholine. J Cardiovasc Pharmacol Ther 2003 Mar; 8 (1): 43-51
45. He J, Yang S, Zhang L. Effects ofcocaine on nitric oxide production in bovine coronary artery endothelial cells. J Pharmacol Exp Ther 2005 Sep; 314 (3): 980-6
46. Togna GI, Graziani M, Russo P, et al. Cocaine toxic effect on endothelium-dependent vasorelaxation: an in vitro study on rabbit aorta. Toxicol Lett 2001 Aug 6; 123 (1): 43-50
47. Amin M, Gabelman G, Karpel J, et al. Acute myocardial infarction and chest pain syndromes after cocaine use. Am J Cardiol 1990 Dec 15; 66 (20): 1434-7
48. Dressler FA, Malekzadeh S, Roberts WC. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol 1990 Feb 1; 65 (5): 303-8
49. Boehrer JD, Moliterno DJ, Willard JE, et al. Hemodynamic effects of intra-nasal cocaine in humans. J Am Coll Cardiol 1992 Jul; 20 (1): 90-3
50. Kolodgie FD, Virmani R, Cornhill JF, et al. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol 1991 Jun; 17 (7): 1553-60
51. Atkinson JB, Harlan CW, Harlan GC, et al. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 1994 Feb; 25 (2): 154-9
52. Lau DC, Dhillon B,YanH, etal. Adipokines: molecular links betweenobesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005 May; 288 (5): H2031-41
53. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003 Jan 28; 107 (3): 363-9
54. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000 Oct 31; 102 (18): 2165-8
55. Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002 Apr 23; 105 (16): 1890-6
56. Siegel AJ, Mendelson JH, Sholar MB, et al. Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen. Am J Cardiol 2002 May 1; 89 (9): 1133-5
57. Meng Q, Lima JA, Lai H, et al. Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users. Int J Cardiol 2003 Apr; 88 (2-3): 191-8
58. Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005 Aug 2; 46 (3): 464-9
59. Albert MA, Glynn RJ, Buring J, et al. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004 May 15; 93 (10): 1238-42
60. Lloyd-Jones DM, Liu K, Tian L, et al. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 2006 Jun 5; (145): 21-29
61. Kugelmass AD, Oda A, Monahan K, et al. Activation of human platelets by cocaine. Circulation 1993 Sep; 88 (3): 876-83
62. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993 Mar; 7 (1): 52-62
63. Heesch CM, Wilhelm CR, Ristich J, et al. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 2000 Jun; 83 (6): 688-95
64. Ruggeri ZM. Von Willebrand factor. J Clin Invest 1997 Feb 15; 99 (4): 559-64
65. Siegel AJ, Sholar MB, Mendelson JH, et al. Cocaine-induced erythrocytosis and increase in von Willebrand factor: evidence for drug-related blood doping and prothrombotic effects. Arch Intern Med 1999 Sep 13; 159 (16): 1925-9
66. Moliterno DJ, Lange RA, Gerard RD, et al. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med 1994 Jun; 96 (6): 492-6
67. Egred M, Davis GK. Cocaine and the heart. Postgrad Med J 2005 Sep; 81 (959): 568-71
68. Hollander JE, Levitt MA, Young GP, et al. Effect of recent cocaine use on the specificity of cardiac markers for diagnosis of acute myocardial infarction. Am Heart J 1998 Feb; 135 (2 Pt 1): 245-52
69. Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 1990 Apr; 88 (4): 325-31
70. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med 1994 Jul-Aug; 1 (4): 330-9
71. Weber JE, Shofer FS, Larkin GL, et al. Validation of a brief observation period for patients with cocaine-associated chest pain. N Engl J Med 2003 Feb 6; 348 (6): 510-7
72. Sharma AK, Hamwi SM, Garg N, et al. Percutaneous interventions in patients with cocaine-associated myocardial infarction: a case series and review. Catheter Cardiovasc Interv 2002 Jul; 56 (3): 346-52
73. Lange RA. Cocaine and myocardial infarction. Johns Hopkins Advanced Studies in Medicine 2003; 3 (8): 448-55
74. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med 2001 Aug 2; 345 (5): 351-8
75. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990 Jun 15; 112 (12): 897-903
76. Hoffman RS. Cocaine and beta-blockers: should the controversy continue? Ann Emerg Med 2008 Feb; 51 (2): 127-9
77. Boehrer JD, Moliterno DJ, Willard JE, et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 1993 Jun; 94 (6): 608-10
78. Cubeddu LX, Fuenmayor N, Varin F, et al. Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol. J Cardiovasc Pharmacol 1987; 10 Suppl. 11: S81-4
79. Page 2nd RL, Utz KJ, Wolfel EE. Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome? Ann Pharmac-other 2007 Dec; 41 (12): 2008-13
80. Sofuoglu M, Brown S, Babb DA, et al. Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug Alcohol Depend 2000 Jul 1; 60 (1): 69-76
81. Fonarow GC, Lukas MA, Robertson M, et al. Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN). Am Heart J 2007 Oct; 154 (4): 637-44
82. Dattilo PB, Hailpern SM, Fearon K, et al. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med 2008 Feb; 51 (2): 117-25
83. Bauman JL, Grawe JJ, Winecoff AP, et al. Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations. J Clin Pharmacol 1994 Sep; 34 (9): 902-11
84. Billman GE. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation. J Pharmacol Exp Ther 1993 Jul; 266 (1): 407-16
85. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 2001 Feb 23; 104 (4): 569-80
86. Marban E. Cardiac channelopathies. Nature 2002 Jan 10; 415 (6868): 213-8
87. Premkumar LS. Selective potentiation of L-type calcium channel currents by cocaine in cardiac myocytes. Mol Pharmacol 1999 Dec; 56 (6): 1138-42
88. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference - endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005 Feb 8; 111 (5): 659-70
89. Weiner RB, Weiner SD, Yurchak PM. Removing the mask. Am J Med 2008 Feb; 121 (2): 113-6
90. Bebarta VS, Summers S. Brugada electrocardiographic pattern induced by cocaine toxicity. Ann Emerg Med 2007 Jun; 49 (6): 827-9
91. Grigorov V, Goldberg L, Foccard JP. Cardiovascular complications of acute cocaine poisoning: a clinical case report. Cardiovasc J S Afr 2004 May-Jun; 15 (3): 139-42
92. Ortega-Carnicer J, Bertos-Polo J, Gutierrez-Tirado C. Aborted sudden death, transient Brugada pattern, and wide QRS dysrhythmias after massive cocaine ingestion. J Electrocardiol 2001 Oct; 34 (4): 345-9
93. Littmann L, Monroe MH, Svenson RH. Brugada-type electrocardiographic pattern induced by cocaine. Mayo Clin Proc 2000 Aug; 75 (8): 845-9
94. Junttila MJ, Gonzalez M, Lizotte E, et al. Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation 2008 Apr 8; 117 (14): 1890-3
95. Gitter MJ, Goldsmith SR, Dunbar DN, et al. Cocaine and chest pain: clinical features and outcome of patients hospitalized to rule out myocardial infarction. Ann Intern Med 1991 Aug 15; 115 (4): 277-82
96. O'Leary ME. Inhibition of human ether-a-go-go potassium channels by cocaine. Mol Pharmacol 2001 Feb; 59 (2): 269-77
97. Tseng GN. I(Kr): the hERG channel. J Mol Cell Cardiol 2001 May; 33 (5): 835-49
98. Magnano AR, Talathoti NB, Hallur R, et al. Effect of acute cocaine administration on the QTc interval of habitual users. Am J Cardiol 2006 Apr 15; 97 (8): 1244-6
99. Grohe C, Meyer R. The cardiac cocaine connection. Cardiovasc Res 2003 Oct 1; 59 (4): 805-6
100. Haigney MC, Alam S, Tebo S, et al. Intravenous cocaine and QT variability. J Cardiovasc Electrophysiol 2006 Jun; 17 (6): 610-6
101. Haigney MC, Zareba W, Gentlesk PJ, et al. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2004 Oct 6; 44 (7): 1481-7
102. Kuczkowski KM. More on the idiosyncratic effects of cocaine on the human heart. Emerg Med J 2007 Feb; 24 (2): 147
103. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 2003 Oct 14; 108 (15): 1871-909
104. Fuster V, O'Rourke R, Walsh R, et al., editors. Hurst's the heart. 12th ed. New York (NY): McGraw-Hill Medical, 2008
105. Hahn IH, Hoffman RS. Cocaine use and acute myocardial infarction. Emerg Med Clin North Am 2001 May; 19 (2): 493-510
106. Kerns 2nd W, Garvey L, Owens J. Cocaine-induced wide complex dysrhythmia. J Emerg Med 1997 May-Jun; 15 (3): 321-9
107. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 8: advanced challenges in resuscitation; section 2, toxicology in ECC. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000 Aug 22; 102 (8 Suppl.): I223-8
108. Shih RD, Hollander JE, Burstein JL, et al. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction. Ann Emerg Med 1995 Dec; 26 (6): 702-6
109. Dewitt CR, Cleveland N, Dart RC, et al. The effect of amiodarone pretreatment on survival of mice with cocaine toxicity. J Med Toxicol 2005 Dec; 1 (1): 11-8
110. Jessup M, Brozena S. Heart failure. N Engl J Med 2003 May 15; 348 (20): 2007-18
111. Crawford M, DiMarco J, Paulus W, et al. Cardiology. 2nd ed. Philadelphia (PA): Mosby, 2003
112. Francis GS. Pathophysiology of chronic heart failure. Am J Med 2001 May 7; 110 (7 Suppl.): 37S-46S
113. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005 May 31; 111 (21): 2837-49
114. Iacobellis G, Kemp W. Cardiomyocyte apoptosis in cocaine-induced myocarditis with involvement of bundle of His and left bundle branch. Int J Cardiol 2006 Sep 10; 112 (1): 116-8
115. Lakoski JM, Rittenhouse PA, Bonadonna AM, et al. Acute, but not repeated, cocaine administration decreases renin secretion in the conscious male rat. Neurosci Lett 1991 Jun 24; 127 (2): 181-4
116. Levy AD, Li Q, Alvarez Sanz MC, et al. Neuroendocrine responses to cocaine do not exhibit sensitization following repeated cocaine exposure. Life Sci 1992; 51 (12): 887-97
117. Levy AD, Rittenhouse PA, Bonadonna AM, et al. Repeated exposure to cocaine produces long-lasting deficits in the serotonergic stimulation of prolactin and renin, but not adrenocorticotropin secretion. Eur J Pharmacol 1993 Sep 14; 241 (2-3): 275-8
118. Levy AD, Rittenhouse PA, Li Q, et al. Cocaine-induced suppression of renin secretion is partially mediated by serotonergic mechanisms. Pharmacol Biochem Behav 1992 Jul; 42 (3): 481-6
119. Hargrave B, Lattanzio F. Cocaine activates the renin-angiotensin system in pregnant rabbits and alters the response to ischemia. Cardiovasc Toxicol 2002; 2 (2): 91-7
120. Brecklin CS, Bauman JL. Cardiovascular effects of cocaine: focus on hypertension. J Clin Hypertens 1999 Nov; 1 (3): 212-7
121. Brecklin CS, Gopaniuk-Folga A, Kravetz T, et al. Prevalence of hypertension in chronic cocaine users. Am J Hypertens 1998 Nov; 11 (11 Pt 1): 1279-83
122. Waspe LE, Ordahl CP, Simpson PC. The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. J Clin Invest 1990 Apr; 85 (4): 1206-14
123. Henning RJ, Silva J, Reddy V, et al. Cocaine increases beta-myosin heavychain protein expression in cardiac myocytes. J Cardiovasc Pharmacol Ther 2000 Oct; 5 (4): 313-22
124. Kariya K, Karns LR, Simpson PC. An enhancer core element mediates stimulation of the rat beta-myosin heavy chain promoter by an alpha 1-adre-nergic agonist and activated beta-protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem 1994 Feb 4; 269 (5): 3775-82
125. Henning RJ, Li Y. Cocaine produces cardiac hypertrophy byprotein kinase C dependent mechanisms. J Cardiovasc Pharmacol Ther 2003 Jun; 8 (2): 149-60
126. Amin JK, Xiao L, Pimental DR, et al. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myo-cytes. J Mol Cell Cardiol 2001 Jan; 33 (1): 131-9
127. Isabelle M, Monteil C, Moritz F, et al. Role of alpha1-adrenoreceptors in cocaine-induced NADPH oxidase expression and cardiac dysfunction. Cardiovasc Res 2005 Sep 1; 67 (4): 699-704
128. Hund TJ, Rudy Y. A role for calcium/calmodulin-dependent protein kinase II in cardiac disease and arrhythmia. Handb Exp Pharmacol 2006; 171: 201-20
129. Henning RJ, Cuevas J. Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte hypertrophy.JCardiovasc Pharmacol 2006 Jul; 48 (1): 802-13
130. Gustafsson AB, Gottlieb RA. Mechanisms of apoptosis in the heart. J Clin Immunol 2003 Nov; 23 (6): 447-59
131. Li G,XiaoY, ZhangL.Cocaine induces apoptosisin fetal rat myocardial cells through the p38 mitogen-activated protein kinase and mitochon-drial/cytochrome c pathways. J Pharmacol Exp Ther 2005 Jan; 312 (1): 112-9
132. Haq S, Choukroun G, Lim H, et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 2001 Feb 6; 103 (5): 670-7
133. Zhang L, Xiao Y, He J. Cocaine and apoptosis in myocardial cells. Anat Rec 1999 Dec 15; 257 (6): 208-16
134. Reed JC, Paternostro G. Postmitochondrial regulation of apoptosis during heart failure. Proc Natl Acad Sci U S A 1999 Jul 6; 96 (14): 7614-6
135. Virmani R, Robinowitz M, Smialek JE, et al. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J 1988 May; 115 (5): 1068-76
136. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000 Nov 9; 343 (19): 1388-98
137. FreireCastroseiros E, PenasLado M, CastroBeiras A. Pathology of the heart of noncardiac origin: VIII, cocaine and the heart. Rev Esp Cardiol 1998 May; 51 (5): 396-401
138. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death - learning from the past for the future. Circulation 1999 Mar 2; 99 (8): 1091-100
139. Wiener RS, Lockhart JT, Schwartz RG. Dilated cardiomyopathy and cocaine abuse: report of two cases. Am J Med 1986 Oct; 81 (4): 699-701
140. Sorescu D, Griendling KK. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 2002 May-Jun; 8 (3): 132-40
141. Byrne JA, Grieve DJ, Cave AC, et al. Oxidative stress and heart failure. Arch Mal Coeur Vaiss 2003 Mar; 96 (3): 214-21
142. Moritz F, Monteil C, Isabelle M, et al. Role of reactive oxygen species in cocaine-induced cardiac dysfunction. Cardiovasc Res 2003 Oct 1; 59 (4): 834-43
143. Isabelle M, Vergeade A, Moritz F, et al. NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. J Mol Cell Cardiol 2007 Feb; 42 (2): 326-32
144. Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. Circulation 1994 Apr; 89 (4): 1580-6
145. Hogya PT, Wolfson AB. Chronic cocaine abuse associated with dilated cardiomyopathy. Am J Emerg Med 1990 May; 8 (3): 203-4
146. Henzlova MJ, Smith SH, Prchal VM, et al. Apparent reversibility of cocaine-induced congestive cardiomyopathy. Am Heart J 1991 Aug; 122 (2): 577-9
147. Om A, Ellahham S, Ornato JP. Reversibility of cocaine-induced cardiomyopathy. Am Heart J 1992 Dec; 124 (6): 1639-41
148. Chokshi SK, Moore R, Pandian NG, et al. Reversible cardiomyopathy associated with cocaine intoxication. Ann Intern Med 1989 Dec 15; 111 (12): 1039-40
149. Hollander JE, Hoffman RS, Gennis P, et al. Cocaine-associated chest pain: one-year follow-up. Acad Emerg Med 1995 Mar; 2 (3): 179-84
150. Dackis CA, O'Brien CP. Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat 2001 Oct; 21 (3): 111-7
151. Gardner TJ, Kosten TR. Therapeutic options and challenges for substances of abuse. Dialogues Clin Neurosci 2007; 9 (4): 431-45
152. Karila L, Gorelick D, Weinstein A, et al. New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol 2008 May; 11 (3): 425-38
153. Martell BA, Mitchell E, Poling J, et al. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry 2005 Jul 15; 58 (2): 158-64
154. Lathers CM, Tyau LS, Spino MM, et al. Cocaine-induced seizures, arrhythmias and sudden death. J Clin Pharmacol 1988 Jul; 28 (7): 584-93
155. Zheng ZJ, Croft JB, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001 Oct 30; 104 (18): 2158-63
156. Schifano F, Corkery J. Cocaine/crack cocaine consumption, treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990-2004). J Psychopharmacol 2008 Jan; 22 (1): 71-9
157. Fineschi V, Centini F, Monciotti F, et al. The cocaine "body stuffer" syndrome: a fatal case. Forensic Sci Int 2002 Mar 28; 126 (1): 7-10
158. Koehler SA, Ladham S, Rozin L, et al. The risk of body packing: a case of a fatal cocaine overdose. Forensic Sci Int 2005 Jun 30; 151 (1): 81-4
159. De Prost N, Lefebvre A, Questel F, et al. Prognosis of cocaine body-packers. Intensive Care Med 2005 Jul; 31 (7): 955-8
160. Sporer KA, Firestone J. Clinical course of crack cocaine body stuffers. Ann Emerg Med 1997 May; 29 (5): 596-601
161. McCance-Katz EF, Kosten TR, Jatlow P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone: a multiple-dose study. Biol Psychiatry 1998 Aug 15; 44 (4): 250-9
162. Randall T. Cocaine, alcohol mix in body to form even longer lasting, more lethal drug. JAMA 1992 Feb 26; 267 (8): 1043-4
163. McCance-Katz EF, Price LH, McDougle CJ, et al. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl) 1993; 111 (1): 39-46
164. Grant BF, Harford TC. Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug Alcohol Depend 1990 Feb; 25 (1): 97-104
165. Brookoff D, Rotondo MF, Shaw LM, et al. Cocaethylene levels in patients who test positive for cocaine. Ann Emerg Med 1996 Mar; 27 (3): 316-20
166. Rounsaville BJ, Anton SF, Carroll K, et al. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991 Jan; 48 (1): 43-51
167. Farre M, de la Torre R, Llorente M, et al. Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther 1993 Sep; 266 (3): 1364-73
168. Farre M, de la Torre R, Gonzalez ML, et al. Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther 1997 Oct; 283 (1): 164-76
169. Perez-Reyes M, Jeffcoat AR. Ethanol/cocaine interaction: cocaine and co-caethylene plasma concentrations and their relationship to subjective and cardiovascular effects. Life Sci 1992; 51 (8): 553-63
170. Perez-Reyes M.The order of drug administration: its effects on the interaction between cocaine and ethanol. Life Sci 1994; 55 (7): 541-50
171. Harris DS, Everhart ET, Mendelson J, et al. The pharmacology of co-caethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend 2003 Nov 24; 72 (2): 169-82
172. Perez-Reyes M. Subjective and cardiovascular effects of cocaethylene in humans. Psychopharmacology (Berl) 1993; 113 (1): 144-7
173. Fuster V, Alexander R, O'Rourke R, editors. Hurst's the heart. 10th ed. New York, London: McGraw-Hill, 2001
174. Hammond AS, Bailey PL. Acute spontaneous coronary artery dissection in the peripartum period. J Cardiothorac Vasc Anesth 2006 Dec; 20 (6): 837-41
175. Almeda FQ, Barkatullah S, Kavinsky CJ. Spontaneous coronary artery dissection. Clin Cardiol 2004 Jul; 27 (7): 377-80
176. Eagle KA, Isselbacher EM, DeSanctis RW. Cocaine-related aortic dissection in perspective. Circulation 2002 Apr 2; 105 (13): 1529-30
177. Pretre R, Von Segesser LK. Aortic dissection. Lancet 1997 May 17; 349 (9063): 1461-4
178. Palmiere C, Burkhardt S, Staub C, et al. Thoracic aortic dissection associated with cocaine abuse. Forensic Sci Int 2004 May 10; 141 (2-3): 137-42
179. Hsue PY, Salinas CL, Bolger AF, et al. Acute aortic dissection related tocrack cocaine. Circulation 2002 Apr 2; 105 (13): 1592-5
180. Steinhauer JR, Caulfield JB. Spontaneous coronary artery dissection associated with cocaine use: a case report and brief review. Cardiovasc Pathol 2001 May-Jun; 10 (3): 141-5
181. Kamineni R, Sadhu A, Alpert JS. Spontaneous coronary artery dissection: report of two cases and a 50-year review of the literature. Cardiol Rev 2002 Sep-Oct; 10 (5): 279-84
182. Arshad A, Mandava A, Kamath G, et al. Sudden cardiac death and the role of medical therapy. Prog Cardiovasc Dis 2008 May-Jun; 50 (6): 420-38
183. Om A, Ellahham S, DiSciascio G. Management of cocaine-induced cardiovascular complications. Am Heart J 1993 Feb; 125 (2 Pt 1): 469-75
184. Derlet RW, Albertson TE, Tharratt RS. Lidocaine potentiation of cocaine toxicity. Ann Emerg Med 1991 Feb; 20 (2): 135-8
185. Anderson JL, Rodier HE, Green LS. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol 1983 Apr; 51 (7): 1196-202
186. Rashid J, Eisenberg MJ, Topol EJ. Cocaine-induced aortic dissection. Am Heart J 1996 Dec; 132 (6): 1301-4
187. Fuller ET, Milling Jr TJ, Price B, et al. Therapeutic hypothermia in cocaine-induced cardiac arrest. Ann Emerg Med 2008 Feb; 51 (2): 135-7
188. Hauer RN, Aliot E, Block M, et al. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Eur Heart J 2001 Jul; 22 (13): 1074-81
189. Chen J, Naseem RH, Obel O, et al. Habitual cocaine use is associated with high defibrillation threshold during ICD implantation. J Cardiovasc Elec-trophysiol 2007 Jul; 18 (7): 722-5